Blueprint Medicines Corporation
Blueprint Medicines Corporation (BPMC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BPMC · as of Jun 9, 2026
Key Statistics
Explore Blueprint Medicines Corporation Data
bpmc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 34 · Buy rate: 52.9%
The BPMC analyst consensus is Buy, based on ratings from 34 Wall Street analysts over the past 3 months. The average 12-month price target is $113.07, representing -12.66% downside from the current price of $129.46.
Competitors & Peers
bpmc competitorsBPMC
CERE
IMGN
ISEE
KRTX
OSHStock Performance
Full HistoryAbout Blueprint Medicines Corporation
Blueprint Medicines Corporation is a biopharmaceutical company dedicated to pioneering precision therapies. Its core mission involves developing innovative treatments for various cancers and specific …
what is blueprint medicines corporation · bpmc stock overview · blueprint medicines corporation company profile · who is blueprint medicines corporation ceo · bpmc NASDAQ · blueprint medicines corporation headquarters · blueprint medicines corporation business segments
About Stock Overview & Key Data
Blueprint Medicines Corporation (BPMC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 30, 2015. As of the latest trading session, BPMC stock price is $129.46, with a market capitalization of $8.4B. The stock has returned +35.28% over the past 12 months and +48.46% year-to-date.
According to 34 Wall Street analysts, the consensus rating for Blueprint Medicines Corporation stock is Buy, with an average 12-month price target of $113.07. In fiscal year 2024, Blueprint Medicines Corporation reported revenue of $508.8M and net income of -$67.1M. For detailed data — including Blueprint Medicines Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Blueprint Medicines Corporation (BPMC) stock price is $129.46. The stock is traded on NASDAQ under the ticker symbol BPMC. The 52-week range is $73.04 – $129.55.